Patent "Evergreening" of Medicine-Device Combination Products: A Global Perspective.
Healthc Policy
; 18(2): 14-26, 2022 10.
Article
em En
| MEDLINE
| ID: mdl-36495532
ABSTRACT
Background:
Patenting medicine-delivery devices (inhalers and pens) is controversial when it extends market protections beyond that of the underlying therapeutic agent. We evaluated how common device patenting is, internationally.Method:
Using a product sample (n = 88) and an international patent database, we assessed the issue's scope.Results:
When comparing the 88 patent portfolios for each product in each country, Canada was found to be among the most impacted, with 90% of the portfolios containing at least one device patent and 35% of the portfolios containing device patents exclusively.Conclusion:
Patenting of delivery devices impacts major pharmaceutical manufacturing centres worldwide. International consensus among stakeholders (regulators and payors) is needed on which device modifications represent meaningful clinical value.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Preparações Farmacêuticas
Limite:
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article